PURPLE Translational Initiatives

The PURPLE Registry supports a number of important pancreatic cancer initiatives including clinical trials, laboratory-based research and screening studies that focus on optimising treatments based on markers that can be detected in a patient's blood or cancer.

PURPLE Registry

The PURPLE Registry was established in 2016 by a team of clinicians and scientists led by Dr Belinda Lee at WEHI.

Goals & Impact

To improve outcomes in pancreatic cancer, it is crucial that greater participation in and access to new drug treatment and clinical trials is encouraged.

Meet the team

Meet the team behind PURPLE.

Steering Committee

Meet our Steering Committee Members.

Researchers & Collaborators

Meet our collaborating researchers.

Funders & Partnerships

The PURPLE Translational Platform is made possible through our generous funders and partnerships.

about us

Copy url

communityrelations@wehi.edu.au

1g Royal Parade, Parkville, VIC, 3052

We acknowledge Aboriginal and Torres Strait Islander peoples as the First Australians and Traditional Custodians of the lands where we live, learn, and work. Cancer Council Victoria resources for Aboriginal Communities

Have a question about PURPLE? Please send us an email at: purplepancreas@wehi.edu.au

Refer a patient Login